A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management
Dena Elkeeb(University of Chicago), David A. Wada(University of Utah), Aaron M. Secrest(University of Canterbury), Keith L. Duffy(University of Utah), Zachary Hopkins(University of Utah), Jamie Zussman(University of Utah), Caitlin M. Bolender(University of Utah), Scott R. Florell(University of Utah), Patricia Vitale(Centro Científico Tecnológico - San Luis), Christopher M. Moreno(Utah Department of Health), Douglas Grossman(University of Utah), Anneli R. Bowen(University of Utah)
Cited by 5
Related Papers
Inhibition of melanoma tumor growth <i>in vivo</i> by survivin targeting
|Proceedings of the National Academy of Sciences|2001|285
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53
|Journal of Clinical Investigation|2001|194
Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19
|JAMA Dermatology|2021|82
Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation
|Cancer Research|2010|81
Influence of Social Media on Cosmetic Procedure Interest.
|PubMed|2020|61